$PRPO News

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

Precipio Q2 EPS $(0.12) Down From $0.05 YoY, Sales $7.021M Up From $5.654M YoY

Precipio Announces Q2-2026 Shareholder Update Call

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Precipio to Present at the Planet MicroCap Las Vegas

Precipio (PRPO) Q1 2026 Earnings Call Transcript

Precipio (PRPO) Q4 2025 Earnings Transcript

Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth

Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges

Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript

Precipio, Inc. Q1 2026 Earnings Call Summary

Precipio Announces Q1 2026 Financial Results

Precipio Q1 EPS $(0.81) Down From $(0.59) YoY, Sales $6.711M Up From $4.929M YoY

Management team’s 2025 market-based Options have vested

B2i Digital Welcomes Precipio, Inc. as a New Featured Company

Precipio Announces Q1-2026 Shareholder Update Call

Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript

Precipio, Inc. Q4 2025 Earnings Call Summary

Precipio Announces Q4 and year-end 2025 Shareholder Update Call

Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay